These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26036710)

  • 1. Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013.
    Bröker M; Emonet S; Fazio C; Jacobsson S; Koliou M; Kuusi M; Pace D; Paragi M; Pysik A; Simões MJ; Skoczynska A; Stefanelli P; Toropainen M; Taha MK; Tzanakaki G
    Hum Vaccin Immunother; 2015; 11(9):2281-6. PubMed ID: 26036710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal serogroup Y emergence in Europe: update 2011.
    Bröker M; Jacobsson S; Kuusi M; Pace D; Simões MJ; Skoczynska A; Taha MK; Toropainen M; Tzanakaki G
    Hum Vaccin Immunother; 2012 Dec; 8(12):1907-11. PubMed ID: 23032167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012.
    Bröker M; Bukovski S; Culic D; Jacobsson S; Koliou M; Kuusi M; Simões MJ; Skoczynska A; Toropainen M; Taha MK; Tzanakaki G
    Hum Vaccin Immunother; 2014; 10(6):1725-8. PubMed ID: 24608912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of meningococcal serogroup Y cases in Europe: a reason for concern?
    Bröker M; Jacobsson S; DeTora L; Pace D; Taha MK
    Hum Vaccin Immunother; 2012 May; 8(5):685-8. PubMed ID: 22508411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014.
    Whittaker R; Dias JG; Ramliden M; Ködmön C; Economopoulou A; Beer N; Pastore Celentano L;
    Vaccine; 2017 Apr; 35(16):2034-2041. PubMed ID: 28314560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent occurrence of serogroup Y/sequence type (ST)-23 complex invasive meningococcal disease among patients aged five to 14 years, Italy, 2007 to 2013.
    Fazio C; Neri A; Renna G; Vacca P; Antonetti R; Barbui AM; Daprai L; Lanzafame P; Rossi L; Santino I; Tascini C; Vocale C; Stefanelli P
    Euro Surveill; 2015; 20(45):. PubMed ID: 26606870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines.
    Pelton SI
    J Adolesc Health; 2016 Aug; 59(2 Suppl):S3-S11. PubMed ID: 27449148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Meningococcal Surveillance Programme annual report, 2014.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E221-8. PubMed ID: 27522133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.
    Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA
    Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017.
    Krone M; Gray S; Abad R; Skoczyńska A; Stefanelli P; van der Ende A; Tzanakaki G; Mölling P; João Simões M; Křížová P; Emonet S; Caugant DA; Toropainen M; Vazquez J; Waśko I; Knol MJ; Jacobsson S; Rodrigues Bettencourt C; Musilek M; Born R; Vogel U; Borrow R
    Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, 1995 to 2012.
    Säll O; Stenmark B; Glimåker M; Jacobsson S; Mölling P; Olcén P; Fredlund H
    Epidemiol Infect; 2017 Jul; 145(10):2137-2143. PubMed ID: 28478773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Based Characterization of Emergent Invasive Neisseria meningitidis Serogroup Y Isolates in Sweden from 1995 to 2012.
    Törös B; Hedberg ST; Unemo M; Jacobsson S; Hill DM; Olcén P; Fredlund H; Bratcher HB; Jolley KA; Maiden MC; Mölling P
    J Clin Microbiol; 2015 Jul; 53(7):2154-62. PubMed ID: 25926489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017.
    Nuttens C; Findlow J; Balmer P; Swerdlow DL; Tin Tin Htar M
    Euro Surveill; 2022 Jan; 27(3):. PubMed ID: 35057902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships Between Clinico-Epidemiological Patterns of Invasive Meningococcal Infections and Complement Deficiencies in French South Pacific Islands (New Caledonia).
    Daures M; John M; Balter CV; Simon O; Barguil Y; Missotte I; Grangeon JP; Laumond-Barny S; Noel M; Besson-Leaud L; Spasic PE; de Suremain A; Gourinat AC; Descloux E
    J Clin Immunol; 2015 Jan; 35(1):47-55. PubMed ID: 25352052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological and genetic characterization of meningococcal isolates in Korea.
    Bae SM; Kang YH
    Jpn J Infect Dis; 2008 Nov; 61(6):434-7. PubMed ID: 19050348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual report of the Australian Meningococcal Surveillance Programme, 2007.
    Tapsall J;
    Commun Dis Intell Q Rep; 2008 Sep; 32(3):299-307. PubMed ID: 19062765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.